Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Borgström

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|April 25, 2003
Real time in vivo quantitation of tumor angiogenesisGregory I Frost, Per Borgström
Life Sciences|October 18, 2002
Low frequency flowmotion/(vasomotion) during patho-physiological conditionsCaroline Schmidt-Lucke, Per Borgström, J André Schmidt-Lucke
Biomed Research International|January 20, 2022
Propylene Glycol Caprylate-Based Nanoemulsion Formulation of Plumbagin: Development and Characterization of Anticancer ActivityAdrian Chrastina, John Welsh, Per Borgström, et al.
American Journal of Cancer Research|October 14, 2011
Intravital microscopy in the mouse dorsal chamber model for the study of solid tumorsVéronique T Baron, John Welsh, Parisa Abedinpour, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2007
Macrophage-mediated bystander effect triggered by tumor cell apoptosisYinghui Huang, Casey Lee, Per Borgström, et al.
The Prostate|April 2, 2011
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivoParisa Abedinpour, Véronique T Baron, John Welsh, et al.
In Vivo (Athens, Greece)|November 6, 2003
The roles of epithelial-mesenchymal interactions and the innate immune response on the tumorigenicity of human prostate carcinoma cell lines grown in immuno-compromised miceGregory I Frost, Brigitte Dudouet, Joseph Lustgarten, et al.
The Prostate|September 22, 2012
The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivoParisa Abedinpour, Véronique T Baron, Adrian Chrastina, et al.
Chemmedchem|May 16, 2020
Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer TherapyAdrian Chrastina, John Welsh, Gaelle Rondeau, et al.
Biomed Research International|December 12, 2018
Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer CellsAdrian Chrastina, Veronique T Baron, Parisa Abedinpour, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|April 25, 2003
Real time in vivo quantitation of tumor angiogenesisGregory I Frost, Per Borgström
Life Sciences|October 18, 2002
Low frequency flowmotion/(vasomotion) during patho-physiological conditionsCaroline Schmidt-Lucke, Per Borgström, J André Schmidt-Lucke
Biomed Research International|January 20, 2022
Propylene Glycol Caprylate-Based Nanoemulsion Formulation of Plumbagin: Development and Characterization of Anticancer ActivityAdrian Chrastina, John Welsh, Per Borgström, et al.
American Journal of Cancer Research|October 14, 2011
Intravital microscopy in the mouse dorsal chamber model for the study of solid tumorsVéronique T Baron, John Welsh, Parisa Abedinpour, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2007
Macrophage-mediated bystander effect triggered by tumor cell apoptosisYinghui Huang, Casey Lee, Per Borgström, et al.
The Prostate|April 2, 2011
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivoParisa Abedinpour, Véronique T Baron, John Welsh, et al.
In Vivo (Athens, Greece)|November 6, 2003
The roles of epithelial-mesenchymal interactions and the innate immune response on the tumorigenicity of human prostate carcinoma cell lines grown in immuno-compromised miceGregory I Frost, Brigitte Dudouet, Joseph Lustgarten, et al.
The Prostate|September 22, 2012
The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivoParisa Abedinpour, Véronique T Baron, Adrian Chrastina, et al.
Chemmedchem|May 16, 2020
Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer TherapyAdrian Chrastina, John Welsh, Gaelle Rondeau, et al.
Biomed Research International|December 12, 2018
Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer CellsAdrian Chrastina, Veronique T Baron, Parisa Abedinpour, et al.
Pageof 2